News

November 19, 2020
Buenos Aires, Argentina, November 19, 2020:  Lockdown due to the COVID-19 pandemic is associated with an increase in high blood pressure among patients admitted to emergency. That’s the finding of a study presented at the 46th Argentine Congress of Cardiology (SAC).
November 19, 2020
Research may lead to identifying novel therapies for cardiac patients
November 19, 2020
- RAPID and completed NODE-301 studies could potentially fulfill efficacy requ
November 18, 2020
November 18, 2020 — Deep vein blockages impact more than 27 million people worldwide. For years, many people suffering from venous disease didn’t have access to advanced treatment options.
November 18, 2020
Only program in New York City to receive prestigious recognition 
November 17, 2020
Arlington, VA (November 17, 2020) — The Society of Cardiovascular Computed Tomography (SCCT), in collaboration with the North American Society of Cardiovascular Imaging (NASCI), has released a new 
November 17, 2020
This cutting-edge technology supports Burlington’s made-to-measure capabilities without the need for in-person fittings.  
November 17, 2020
DALLAS, Nov. 17, 2020 -- The investigational medication finerenone reduced the risk of heart attack, stroke, heart failure and other negative cardiovascular events in patients with chronic kidney disease and Type 2 diabetes, according to late-breaking research presented at the American Heart Association's Scientific Sessions 2020.
November 16, 2020
Mount Sinai clinical trial results could help lead to FDA approval (New York, NY – November 16, 2020) – Empagliflozin, a recently developed diabetes drug, can effectively treat and reverse heart failure in both diabetic and non-diabetic patients, according to researchers at the Icahn School of Medicine at Mount Sinai.